» Articles » PMID: 29544384

Complications and Adequacy of Transplant Kidney Biopsies: A Comparison of Techniques

Overview
Journal J Vasc Access
Publisher Sage Publications
Date 2018 Mar 17
PMID 29544384
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Kidney biopsies are an essential tool in the diagnosis and management of kidney diseases, particularly in kidney transplant recipients. Biopsies carry a risk for serious complications and not all biopsies achieve adequate tissue. We examined the impact of kidney biopsy technique on complications and biopsy adequacy.

Methods: The cohort consisted of consecutive kidney transplant patients undergoing biopsy by one of three techniques: ultrasound localization, real-time ultrasound guidance, and ultrasound-guided trocar placement. Variables of interest included patient characteristics and procedural characteristics. The primary outcome was serious complication attributable to kidney biopsy, and the secondary outcome was biopsy adequacy as defined by Banff criteria.

Results: Among 263 patients undergoing biopsy, 27 (10.3%) had a complication (14 with gross hematuria, 10 requiring blood transfusion, 3 requiring an unplanned interventional radiology procedure, 1 kidney loss; no deaths). Complications were more common among patients biopsied using ultrasound-guided trocar compared to real-time ultrasound and ultrasound localization (21.4% vs 7.9% vs 7.1%, respectively, p = 0.008). After adjusting for patient and procedure characteristics, technique was no longer significantly associated with complication. Biopsy adequacy was significantly higher when using ultrasound localization and real-time ultrasound compared to ultrasound-guided trocar (84.6% vs 86.8% vs 69.6%, p = 0.029), and this finding persisted in adjusted analysis.

Conclusion: Kidney biopsy complications appear to be similar when using any of the three techniques examined in our study. However, ultrasound-guided trocar technique may yield lower biopsy adequacy when compared to non-trocar techniques.

Citing Articles

Predicting Cellular Rejection of Renal Allograft Based on the Serum Proteomic Fingerprint.

Ramalhete L, Vieira M, Araujo R, Vigia E, Aires I, Ferreira A Int J Mol Sci. 2024; 25(7).

PMID: 38612654 PMC: 11011520. DOI: 10.3390/ijms25073844.


Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective.

Rizvi A, Faiz S, Thakkar P, Hussain S, Gamilla-Crudo A, Kueht M J Pers Med. 2023; 13(8).

PMID: 37623456 PMC: 10455393. DOI: 10.3390/jpm13081205.


Extracellular Vesicles: The Future of Diagnosis in Solid Organ Transplantation?.

Romero-Garcia N, Huete-Acevedo J, Mas-Bargues C, Sanz-Ros J, Dromant M, Badenes R Int J Mol Sci. 2023; 24(6).

PMID: 36982182 PMC: 10048932. DOI: 10.3390/ijms24065102.


Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders.

Savino F, Rigali F, Giustini V, DAliberti D, Spinelli S, Piazza R Cancers (Basel). 2022; 14(21).

PMID: 36358796 PMC: 9654765. DOI: 10.3390/cancers14215378.


Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation.

Akalin E, Weir M, Bunnapradist S, Brennan D, Delos Santos R, Langone A Kidney360. 2022; 2(12):1998-2009.

PMID: 35419538 PMC: 8986041. DOI: 10.34067/KID.0005062021.